FGF23 and chronic kidney disease: Experimental and clinical evidences point out a role of FGF-23 in CKD-associated cardiac hypertrophy since FGF-23 increases in patients with CKD and its concentration is correlated to cardiac hypertrophy (Faul et al., 2011; Isakova et al., 2011).